|  Help  |  About  |  Contact Us

Publication : Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II.

First Author  Shung CY Year  2012
Journal  Hum Mol Genet Volume  21
Issue  21 Pages  4628-44
PubMed ID  22843502 Mgi Jnum  J:187998
Mgi Id  MGI:5438881 Doi  10.1093/hmg/dds305
Citation  Shung CY, et al. (2012) Disruption of a Sox9-beta-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II. Hum Mol Genet 21(21):4628-44
abstractText  Mutations in fibroblast growth factor (FGF) receptors are responsible for a variety of skeletal birth defects, but the underlying mechanisms responsible remain unclear. Using a mouse model of thanatophoric dysplasia type II in which FGFR3(K650E) expression was directed to the appendicular skeleton, we show that the mutant receptor caused a block in chondrocyte differentiation specifically at the prehypertrophic stage. The differentiation block led to a severe reduction in hypertrophic chondrocytes that normally produce vascular endothelial growth factor, which in turn was associated with poor vascularization of primary ossification centers and disrupted endochondral ossification. We show that the differentiation block and defects in joint formation are associated with persistent expression of the chondrogenic factor Sox9 and down-regulation of beta-catenin levels and activity in growth plate chondrocytes. Consistent with these in vivo results, FGFR3(K650E) expression was found to increase Sox9 and decrease beta-catenin levels and transcriptional activity in cultured mesenchymal cells. Coexpression of Fgfr3(K650E) and Sox9 in cells resulted in very high levels of Sox9 and cooperative suppression of beta-catenin-dependent transcription. Fgfr3(K650E) had opposing effects on Sox9 and beta-catenin protein stability with it promoting Sox9 stabilization and beta-catenin degradation. Since both Sox9 overexpression and beta-catenin deletion independently blocks hypertrophic differentiation of chondrocytes and cause chondrodysplasias similar to those caused by mutations in FGFR3, our results suggest that dysregulation of Sox9 and beta-catenin levels and activity in growth plate chondrocytes is an important underlying mechanism in skeletal diseases caused by mutations in FGFR3.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

23 Bio Entities

Trail: Publication

0 Expression